Financial Information

Balance Sheet

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current Assets    
Cash $ 407,272 $ 141,379
Trade accounts receivable, net 175,631 128,190
Other receivables
Product deposit 106,700 16,500
Inventory, net 623,446 681,258
Other current assets 251,184
Assets held for sale 296,483
Total Current Assets 1,564,233 1,263,810
Non-current assets    
Intangible assets, net 335,131
Total non-current assets 335,131
Total Assets 1,899,364 1,263,810
Current Liabilities    
Accounts payable and accrued expenses 684,274 391,759
Notes payable 167,479
Convertible notes payable, net
Deferred revenue 15,608
Liabilities held for sale 81,733
Total Current Liabilities 699,882 640,971
Stockholders' Equity (Deficit)    
Common stock, $0.01 par value; 100,000,000 shares authorized, 45,334,957 and 44,493,063 shares issued, 44,819,757 and 43,977,863 outstanding as of September 30, 2018 and December 31, 2017, respectively 453,349 444,930
Additional paid-in capital 12,339,491 11,500,537
Accumulated deficit (11,375,579) (10,899,843)
Equity 1,417,261 1,045,624
Treasury stock, 515,200 and 515,200 shares, at cost (163,701) (163,701)
Total Conversion Labs, Inc. Stockholders' Equity (Deficit) 1,253,560 881,923
Non-controlling interest (54,078) (259,084)
Total Stockholders' Equity (Deficit) 1,199,482 622,839
Total Liabilities and Stockholders' Equity (Deficit) $ 1,899,364 $ 1,263,810

Source